Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma

BACKGROUND: Fibulin-3 is a new potential biomarker for malignant mesothelioma (MM). This study evaluated the potential applicability of fibulin-3 plasma levels as a biomarker of response to treatment and its prognostic value for progressive disease within 18 months. The potential applicability of fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovac, Viljem, Dodic-Fikfak, Metoda, Arneric, Niko, Dolzan, Vita, Franko, Alenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577225/
https://www.ncbi.nlm.nih.gov/pubmed/26401134
http://dx.doi.org/10.1515/raon-2015-0019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577225/
https://www.ncbi.nlm.nih.gov/pubmed/26401134
http://dx.doi.org/10.1515/raon-2015-0019

Ejemplares similares